Startseite The crystal structure of 4-(6-acetyl-5-methyl-4,7-dihydrotetrazolo[1,5-a]pyrimidin-7-yl)benzonitrile, C14H12N6O
Artikel Open Access

The crystal structure of 4-(6-acetyl-5-methyl-4,7-dihydrotetrazolo[1,5-a]pyrimidin-7-yl)benzonitrile, C14H12N6O

  • Wenxiang Wang ORCID logo EMAIL logo
Veröffentlicht/Copyright: 26. April 2021

Abstract

C14H12N6O, monoclinic, P21/c (no. 14), a = 17.827(4) Å, b = 11.021(2) Å, c = 7.0936(14) Å, β = 100.59(3)°, V = 1370.0(5) Å3, Z = 4, Rgt(F) = 0.0824, wRref(F2) = 0.2208, T = 293 K.

CCDC no.: 2065026

The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Colorless prism
Size:0.38 × 0.18 × 0.16 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:0.09 mm−1
Diffractometer, scan mode:Bruker P4, ω
θmax, completeness:27.5°, >99%
N(hkl)measured, N(hkl)unique, Rint:13,141, 3109, 0.080
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 2098
N(param)refined:190
Programs:CrystalClear [1], Olex2 [2], SHELX [3], [4], Diamond [5]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
O10.18894 (17)0.1203 (3)0.3687 (4)0.0760 (9)
N10.07279 (14)−0.1021 (3)1.0839 (4)0.0456 (7)
N20.12557 (15)−0.1869 (3)1.1583 (4)0.0500 (7)
N30.18428 (14)−0.1836 (2)1.0767 (4)0.0442 (7)
N40.17045 (13)−0.0947 (2)0.9432 (3)0.0337 (5)
N50.07367 (14)0.0416 (2)0.8264 (4)0.0443 (7)
H50.0333140.0798740.8425750.053*
N60.5348 (2)0.1756 (3)1.4104 (6)0.0848 (12)
C10.10313 (15)−0.0473 (3)0.9500 (4)0.0349 (6)
C20.0623 (2)0.1581 (4)0.5385 (5)0.0603 (10)
H2A0.0159920.1766780.5835280.090*
H2B0.0909350.2312240.5322080.090*
H2C0.0500410.1223900.4131050.090*
C30.10891 (17)0.0703 (3)0.6738 (4)0.0406 (7)
C40.17748 (16)0.0227 (3)0.6597 (4)0.0367 (7)
C50.21355 (19)0.0453 (3)0.4905 (4)0.0468 (8)
C60.2827 (2)−0.0262 (4)0.4709 (5)0.0621 (10)
H6A0.294985−0.0811170.5770680.093*
H6B0.272841−0.0714170.3532510.093*
H6C0.3247800.0279770.4696080.093*
C70.22207 (15)−0.0593 (3)0.8137 (4)0.0340 (6)
H70.237281−0.1325040.7518950.041*
C80.29329 (15)−0.0017 (3)0.9321 (4)0.0345 (6)
C90.35549 (16)−0.0746 (3)0.9999 (4)0.0421 (7)
H90.355020−0.1559240.9648830.051*
C100.41976 (17)0.0936 (3)1.1697 (4)0.0439 (8)
C110.35837 (18)0.1682 (3)1.0986 (5)0.0486 (8)
H110.3596830.2500511.1308350.058*
C120.29525 (17)0.1201 (3)0.9795 (4)0.0434 (7)
H120.2540170.1697910.9311900.052*
C130.4846 (2)0.1418 (4)1.3034 (5)0.0597 (10)
C280.41855 (17)−0.0265 (3)1.1201 (5)0.0469 (8)
H280.460099−0.0758301.1670740.056*

Source of material

4-Formylbenzonitrile (10 mmol), pentane-2,4-dione (10 mmol), 5-aminotetrazole (10 mmol), 7.5 mL propane-1,2-diol and 2 mL water were added successively into a 25 mL reaction vessel, stirred well before the mixture was sealed in the vessel. The mixture was kept at 120 °C for 12 h before it was cooled to room temperature. The reaction solution was poured into 50 mL distilled water, stirred vigorously for 10 min, and then the solid of crude tetrazolopyrimidine was filtered out. Recrystallization from methanol and DMF gave the crystal product.

Experimental details

All the hydrogen atoms were calculated geometrically with C–H distances ranging from 0.93 to 0.98 A. Caryl–H = 0.93 Å, with Uiso(H) = 1.2Ueq(C). Cmethyl–H = 0.96 Å, with Uiso(H) = 1.5Ueq(C).

Comment

Pyrimidines are a very important class of substances in life activities [6]. They are widely present in the human body and other organisms. For example, among the five most common nitrogen-containing basic components in nucleic acids, there are three pyrimidine-containing structures. Pyrimidine compounds have received widespread attention because of their strong biological activities [7]. Medicines containing pyrimidine rings mainly focus on anti-tumor [8] and virus aspects [9], including very important anti-hepatitis B virus varieties and anti-HIV varieties [10]. Pesticides containing pyrimidine rings have excellent performance in the three major fields of weeding, insecticide and sterilization and even plant growth regulators [11].

Under hydrothermal and solvothermal conditions, with special physical and chemical properties of various solvents in the subcritical or supercritical state [12], the activity of the reactants was greatly enhanced, the required reaction temperature was greatly reduced, the development of low-temperature synthetic chemistry was promoted, new chemical reactions were discovered.

In the title molecule, C14H12N6O, all bond lengths are in normal ranges [13], [14]. The plane of the tetrazole ring forms dihedral angles of 77.56(9)° with the phenyl ring. The pyrimidine ring is in a flattened boat conformation. In the crystal, N–H⋅⋅⋅N hydrogen bonds stabilize the molecular structure.


Corresponding author: Wenxiang Wang, Jiangsu Vocational Institute of Architectural Technology, Xuzhou221116, People’s Republic of China, E-mail:

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Rigaku. CrystalClearSM Expert; Rigaku Corporation: Tokyo, Japan, 2005.Suche in Google Scholar

2. Bourhis, L. J., Dolomanov, O. V., Gildea, R. J., Howard, J. A. K., Puschmann, H. The anatomy of a comprehensive constrained, restrained refinement program for the modern computing environment–Olex2 dissected. Acta Crystallogr. 2015, A71, 59–75; https://doi.org/10.1107/s2053273314022207.Suche in Google Scholar

3. Sheldrick, G. M. SHELXTL – integrated space-group and crystal-structure determination. Acta Crystallogr. 2015, A71, 3–8; https://doi.org/10.1107/s2053273314026370.Suche in Google Scholar

4. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Suche in Google Scholar

5. Brandenburg, K. DIAMOND. Visual Crystal Structure Information System (Ver. 4.0); Crystal Impact: Bonn, Germany, 2015.Suche in Google Scholar

6. Gein, V. L., Vladimirov, I. N., Fedorova, O. V., Kurbatova, A. A., Nosova, N. V., Krylova, I. V., Vakhrin, M. I. Synthesis of alkyl 5-aryl-7-methyl-1,5-dihydrotetrazolo-[1,5-a]pyrimidine-6-carboxylates. Russ. J. Org. Chem. 2010, 46, 699–705; https://doi.org/10.1134/s1070428010050180.Suche in Google Scholar

7. Tkachenko, I. G., Komykhov, S. A., Musatov, V. I., Shishkina, S. V., Dyakonenko, V. V., Shvets, V. N., Diachkov, M. V., Chebanov, V. A., Desenko, S. M. In water multicomponent synthesis of low-molecular-mass 4,7-dihydrotetrazolo[1,5-a]pyrimidines. Beilstein J. Org. Chem. 2019, 15, 2390–2397; https://doi.org/10.3762/bjoc.15.231.Suche in Google Scholar

8. Saira, M., Yang, J. Q., Tariq, Q., Mei, H. Z., Yang, Z. L., Hu, Y., Cao, W. L., Valery, P. S., Zhang, J. G. Tetrazole and azido derivatives of pyrimidine: synthesis, mechanism, thermal behaviour & steering of azido–tetrazole equilibrium. ChemistrySelect 2020, 5, 5414–5421.10.1002/slct.202001087Suche in Google Scholar

9. Wang, X. C., Wei, Y., Da, Y. X., Zhang, Z., Quan, Z. J. One-step synthesis of tetrazolo[1,5-a]pyrimidines by cyclization reaction of dihydropyrimidine-2-thiones with sodium azide. Heterocycles 2011, 83, 2811–2822; https://doi.org/10.3987/com-11-12351.Suche in Google Scholar

10. Shen, S. D., Feng, X. D., Yang, W. H., Yao, C. S. Ethyl 7-(4-bromophenyl)-5-trifluoromethyl-4,7-dihydrotetrazolo[1,5- a]pyrimidine-6-carboxylate. Acta Crystallogr. 2010, E66, o2421; https://doi.org/10.1107/s1600536810033842.Suche in Google Scholar

11. Haleel, A., Arthi, P., Dastagiri Reddy, N., Veena, V., Sakthivel, N., Arun, Y., Perumal, P. T., Rahiman, A. K. DNA binding, molecular docking and apoptotic inducing activity of nickel(II), copper(II) and zinc(II) complexes of pyridine-based tetrazolo[1,5-a]pyrimidine ligands. RSC Adv. 2014, 4, 60816–60830; https://doi.org/10.1039/c4ra11197d.Suche in Google Scholar

12. Li, T. J., Yao, C. S., Yu, C. X., Wang, X. S., Tu, S. J. Ionic liquid–mediated one-pot synthesis of 5-(trifluoromethyl)-4,7-dihydrotetrazolo[1,5- a]pyrimidine derivatives. Synth. Commun. 2012, 42, 2728–2738; https://doi.org/10.1080/00397911.2011.566460.Suche in Google Scholar

13. Price, I. K., Rougeot, C., Hein, J. E. Crystal structure of 5,7-diphenyl-4,7-dihydrotetrazolo[1,5-a]pyrimidine. Acta Crystallogr. 2015, E71, o220; https://doi.org/10.1107/s2056989015002996.Suche in Google Scholar

14. Fang, B., Meng, J. P., Luo, Y. Crystal structure of methyl 2-(4-(pyrazolo[1,5-a] pyrimidin-6-yl)phenyl)acetate, C15H13N3O2. Z. Kristallogr. NCS 2019, 234, 395–396; https://doi.org/10.1515/ncrs-2018-0224.Suche in Google Scholar

Received: 2021-03-24
Accepted: 2021-04-12
Published Online: 2021-04-26
Published in Print: 2021-07-27

© 2021 Wenxiang Wang, published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of poly[(μ2-aqua-tetraaqua-(μ3-glutarato-κ4O,O′:O′:O′′)-(μ5-glutarato-κ6O:O,O′:O′:O′′:O′′′)distrontium(II)], C10H22O13Sr2
  4. The crystal structure of acetato-κ1O-{(2-(2-(2-aminophenoxy)ethoxy)phenyl)(4-oxo-4-phenylbut-2-en-2-yl)amido-κ2N,N′,O}copper(II), C26H26CuN2O5
  5. Crystal structure of dimethanolato-k2O:O-bis(1-((2-methyl-1H-benzo[d]imidazol-1-yl)methyl)-1H-benzo[d][1,2,3]triazole-κN)-bis(thiocyanato-κN)dicopper(II), C34H32Cu2N12O2S2
  6. Crystal structure of poly[diaqua-bis(μ2-3-(pyrimidin-5-yl)benzoato-κ2N:O)cobalt(II)] dihydrate, [Co(C11H11O2N2)2(H2O)2]
  7. Crystal structure of bis(3,3-dimethyl-1-phenylbut-1-en-2-yl)(trimethylsilyl)amido-k1N)zinc(II), Zn(C15H24NSi)2
  8. Crystal structure of catena-poly[(μ2-methanolato-κ2O:O)-(μ2-1-((2-methyl-1H-benzo[d]imidazol-1-yl)methyl)-1H-benzo[d][1,2,3]triazole-κ2N:N′)-(thiocyanato-κ1N)copper(II)] 0.25 hydrate, C17H16CuN6OS ⋅ 0.5H2O
  9. The crystal structure of 2-amino-5-nitroanilinium iodide monohydrate, C6H8IN3O2
  10. The crystal structure of 3-amino-5-carboxypyridin-1-ium perchlorate monohydrate, C6H9ClN2O7
  11. Crystal structure of 7-hydroxy-2,4-dimethoxy-9,10-dihydrophenanthrene from Arundina graminifolia, C16H16O3
  12. Crystal structure of 6,6′-((1E, 1′E)-(((1R, 2R)-1,2-diphenylethane-1,2-diyl) bis(azanylylidene))bis(methanylylidene))bis(2-ethylphenol), C32H32N2O2
  13. The crystal structure of 2-amino-5-carboxypyridin-1-ium iodide monohydrate, C6H9IN2O3
  14. The crystal structure of 2-(3,5-difluorophenyl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborinine, C16H11BF2N2
  15. Crystal structure of bis{(2-pyridinyl)-1-phenyl-1-isopropylmethanolato-κ2N,O}nickel, C30H32N2NiO2
  16. Crystal structure of poly[(m3-3-carboxyadamantane-1-carboxylato-κ3O:O′:O″)-(phenanthroline-κ2N,N′)sodium(II)], C24H23N2NaO4
  17. Crystal structure of 2-phenylethynyl-1,3,6,8-tetramethylBOPHY (BOPHY = bis(difluoroboron)-1,2-bis((1H-pyrrol-2-yl)methylene)hydrazine), C22H20B2F4N4
  18. Crystal structure of 4-tert-butyl-2-N-(2-pyridylmethyl)aminophenol, C16H20N2O
  19. The crystal structure of (3Z,3′Z)-4,4′-((1,4-phenylenebis(methylene))bis(azanediyl))bis(pent-3-en-2-one), C18H24N2O2
  20. Crystal structure of (morpholine-1-carbodithioato-κ2-S,S′)bis(triphenylphosphine-κ-P)gold(I), C41H38AuNOP2S2
  21. Crystal structure of 1,4-bis(4-bromobenzyl)-4-(4-chlorophenyl)-1,4-dihydropyridine-3-carbonitrile, C26H19Br2ClN2
  22. The crystal structure of fac-tricarbonyl (N′-benzoyl-N,N-diphenylcarbamimidothioato-κ2S,O)-(pyrazole-κN)rhenium(I) — methanol (1/1) C26H23O4N4SRe
  23. The crystal structure of Ba2Mn(SeO3)2Cl2 containing 1[Mn(SeO3)2Cl2]4− chains
  24. Crystal structure of 3,3′,3″-((1E,1′E,1″E)-((nitrilotris(ethane-2,1-diyl))tris(azaneylylidene)) tris(methaneylylidene))tris(4-hydroxy-1-naphthaldehyde) monohydrate, C42H36N4O6·H2O
  25. The crystal structure of 4-(6-acetyl-5-methyl-4,7-dihydrotetrazolo[1,5-a]pyrimidin-7-yl)benzonitrile, C14H12N6O
  26. Crystal structure of benzo[d][1,3]dioxol-5-yl-2-(6-methoxynaphthalen-2-yl)propanoate, C21H18O5
  27. The crystal structure of ethyl 5-methyl-7-(4-(phenylthio)phenyl)-4,7-dihydrotetrazolo[1,5-a]pyrimidine-6-carboxylate, C20H19N5O2S
  28. Crystal structure of N′,N‴-((propane-2,2-diylbis(1H-pyrrole-5,2-diyl))bis(methaneylylidene))-di(isonicotinohydrazide)– water – dimethylformamide (1/4/2), C25H24N8O2·4H2O·2C3H7NO
  29. Synthesis and crystal structure of 4-(2,4-dinitrophenoxy)benzaldehyde, C13H8N2O6
  30. The crystal structure of 1-dodecylpyridin-1-ium bromide monohydrate, C17H32BrNO
  31. Crystal structure of (E)-amino(2-(4-(dimethylamino)benzylidene)hydrazineyl)methaniminium nitrate, C10H16N6O3
  32. Crystal structure of (E)-(2-((1H-pyrrol-2-yl)methylene)hydrazineyl)(amino)methaniminium nitrate monohydrate, C6H12N6O4
  33. The crystal structure of hexakis(1-propylimidazole-κ1N)copper(II) dichloride, C36H60Cl2CuN12
  34. The crystal structure of bis{(μ2-3,3-dimethyl-1-phenylbut-1-en-2-yl)((dimethylamino)dimethylsilyl)amido-κ3N,N′:N′}dilithium, C32H54Li2N4Si2
  35. The crystal structure of methyl 4-(1H-naphtho[1,8-de][1,3,2]diazaborinin-2(3H)-yl)benzoate, C18H15BN2O2
  36. Crystal structure of (E)-N-(1-((2-chlorothiazol-5-yl)methyl)pyridin-2(1H)-ylidene)-2,2,2-trifluoroacetamide, C11H7ClF3N3OS
  37. Crystal structure of N′, N‴-((propane-2,2-diylbis(1H-pyrrole-5,2-diyl))bis (methaneylylidene))di(picolinohydrazide) – water – methanol (1/1/1), C25H24N8O2·H2O·CH3OH
  38. Crystal structure of 3-(2-chloro-benzyl)-7-[4-(2-chloro-benzyl)-piperazin-1-yl]-5,6,8-trifluoro-3H-quinazolin-4-one, C26H21Cl2F3N4O
  39. Crystal structure of N1,N2-bis(2-fluorobenzyl)benzene-1,2-diamine,C20H18F2N2
  40. The crystal structure of 2-(benzo[d][1,3]dioxol-5-yl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborinine, C17H13BN2O2
  41. The crystal structure of 6,6′-((1E,1′E)-hydrazine-1,2-diylidenebis(methaneylylidene)) bis(2-bromo-4-nitrophenol) — dimethylsulfoxide (1/2), C14H8Br2N4O6⋅2(C2H6OS)
  42. Selective biocatalytic synthesis and crystal structure of (2R,6R)-hydroxyketaminium chloride, C13H17Cl2NO2
  43. Crystal structure of bis{tetraaqua-[μ3-1-(4-carboxylatophenyl)-5-methyl-1H-pyrazole-3-carboxylate-κ4N,O,O′,O″] [μ2-1-methyl-1H-pyrazole-3,5-dicarboxylate-κ3N,O:O]dicobalt(II)} dihydrate, C36H44Co4N8O26
  44. Crystal structure of diethyl-2,2′-naphthalene-2,3-diylbis(oxy)diacetate, C18H20O6
  45. Synthesis and crystal structure of poly[(μ3-2-(2-carboxylatophenyl)-1H-benzo[d]imidazole-5-carboxylato-κO,O′:O′;:O″, O″′)-(μ2-1-(4-(1Himidazol-1-yl)phenyl)-1H-imidazole-κ2N:N′)cadmium(II)], C27H18CdN6O4
  46. The crystal structure of catena-poly[diaqua-bis(μ2-2-((2-(2-phenylacetyl)hydrazineylidene)methyl)benzoato-κ2O:O')zinc(II)], C32H30N4O8Zn
  47. The crystal structure of 2-(3,4-dimethoxyphenyl)-2,3-dihydro-1H-naphtho [1,8-de][1,3,2]diazaborinine, C18H17BN2O2
  48. The crystal structure of hexakis(1-ethylimidazole-κ1N)nickel(II) dichloride – 1-ethylimidazole (1/2), C40H64Cl2NiN16
  49. Crystal structure of diaqua-bis(2,4-dinitrophenolato-κ2O,O′)copper(II) 1.5 hydrate, C12H13CuN4O13.5
  50. Crystal structure of N′,N‴-((1E,1′E)-((decane-1,10-diylbis(oxy))bis(2,1-phenylene)) bis(methaneylylidene))di(isonicotinohydrazide), C36H40N6O4
  51. The crystal structure of 2-[(R)-1-(naphthalen-1-yl)ethyl]-2,3,7,7a-tetrahydro-3a,6-epoxyisoindol-1(6H)-one, C19H20NO2
  52. Synthesis and crystal structure of (1E,2E)-3-(anthracen-9-yl)-1-(4-methoxyphenyl)prop-2-en-1-one oxime, C24H19NO2
  53. Synthesis and crystal structure of (2E,2′E)-3,3′-(1,3-phenylene)bis(1-(3-bromophenyl)prop-2-en-1-one), C24H16Br2O2
  54. The crystal structure of catena-poly[bis(µ2-1,2-bis((1H-imidazol-1-yl)methyl)benzene- κ2N:N′)-bis(nitrato-κO)copper(II)], C28H28N10O6Cu
  55. Synthesis and crystal structure of the novel chiral acetyl-3-thiophene-5-(9-anthryl)-2-pyrazoline, C23H18N2OS
  56. Crystal structure of (E)-3-(dimethylamino)-1-(thiophen-3-yl)prop-2-en-1-one, C9H11NOS
  57. Crystal structure of catena-poly[aqua-(4-iodopyridine-2,6-dicarboxylato-κ3N,O,O′)-(μ2-4-amino-4H-1,2,4-triazole-κ2N:N′) copper(II)], C9H8N5O5CuI
  58. Crystal structure of cyclopropane-1,2,3-triyltris(phenylmethanone), C24H18O3
  59. Crystal structure of bis(amino(thioureido)methaniminium) terephthalate, C12H18N8O4S2
  60. A three-dimensional Eu(III) framework in the crystal structure of dimethylaminium poly[dimethylformamide-κ1N)bis(μ4-terephthalato-κ4O:O′:O′′:O′′′)europium(III)] monohydrate, C21H25EuN2O10
  61. Crystal structure of 2-methoxyphenyl 2-(6-methoxynaphthalen-2-yl)propanoate, C21H20O4
  62. The crystal structure of Hexakis(diethylamido)dimolybdenum, Mo2(NEt2)6
Heruntergeladen am 23.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2021-0106/html
Button zum nach oben scrollen